Key result
Complete resection of a 32-cm giant retroperitoneal liposarcoma achieves good recovery while sparing other organs.
Why the study?
Liposarcoma is a rare malignant tumor where surgical resection is the gold standard, and this report aims to help clinical oncologists understand and treat giant retroperitoneal liposarcoma.
Case Report (n=1)
No
Complete surgical resection without removal of adjacent organs is feasible and key to treating giant retroperitoneal liposarcoma.
Answers are grounded in this paper and cite their sources.
Supports organ-preserving resection feasibility in giant retroperitoneal liposarcoma; leaves open generalizability and S-100 diagnostic role pending larger series.
Liposarcoma is a rare malignant tumor type and surgical resection is the gold standard treatment. The present study reported on the case of a 51-year-old woman who presented with a mass in the left upper abdomen. Computed tomography revealed a 32-cm giant retroperitoneal liposarcoma. Complete tumor resection was performed without the removal of other organs. Postoperative pathological examination indicated retroperitoneal well-differentiated liposarcoma and immunohistochemistry revealed S-100(-), MDM2(+), vimentin(+), CDK4(+), p16(+) and STAT6(+) results. The patient recovered well after the surgery. Complete tumor resection during the first surgery is key to cure liposarcoma. The present case report will be helpful for clinical oncologists to fully understand giant retroperitoneal liposarcoma and treat it accordingly.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2022) conducted a case report in Giant retroperitoneal liposarcoma (n=1). Complete surgical resection was evaluated on Tumor resection and patient recovery. Complete surgical resection of a 32-cm giant retroperitoneal liposarcoma was successfully performed without removal of other organs, leading to good patient recovery.
Synapse has enriched 10 related papers. Consider them for comparative context: